The immune-dependence of chemotherapy in experimental schistosomiasis
Experimental evidence indicates that immune effector mechanisms can enhance the activity of schistosomicidal drugs. Praziquantel, oxamniquine, hycanthone and antimony were less effective against Schistosoma mansoni infections in mice immunosuppressed by T cell-deprivation, than against comparable in...
Main Author: | M. J. Doenhoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
1989-01-01
|
Series: | Memorias do Instituto Oswaldo Cruz |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761989000500004 |
Similar Items
-
Experimental chemotherapy of Schistosomiasis III: laboratory and clinical trials with trichlorphone, an organophosphorus compound
by: Naftale Katz, et al.
Published: (1968-10-01) -
Optimising cluster survey design for planning schistosomiasis preventive chemotherapy
by: Knowles, S, et al.
Published: (2017) -
Schistosomiasis: Review of an immune complex disease
by: Yusuf EO
Published: (2018-08-01) -
Recent advances in immunity to human schistosomiasis
by: Paul Hagan, et al.
Published: (1992-01-01) -
Experimental animal models in vaccination against schistosomiasis
by: Diane J. Mclaren
Published: (1989-01-01)